Home > Healthcare > Medical Devices > Diagnostic Devices > Anatomic Pathology Market

Anatomic Pathology Market Share

Report ID: GMI12097
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Anatomic Pathology Market Share

The market is highly competitive, featuring a blend of leading global companies and smaller to medium-sized enterprises striving for market share. A key component of market strategy is the ongoing development of innovative technologies and diagnostic methods, such as digital pathology and advanced molecular testing. Prominent industry leaders play a significant role in shaping the market, often spearheading advancements through substantial investments in research and development.

Furthermore, mergers, acquisitions, and strategic alliances are essential for strengthening market positions and expanding global presence in response to shifting healthcare demands and regulatory standards. The increasing focus on precision medicine, personalized diagnostics, and high-quality laboratory practices continues to influence the competitive landscape, impacting service offerings and fostering trust in anatomic pathology services among healthcare providers and patients.

Anatomic Pathology Market Companies

Some of the eminent market participants operating in the anatomic pathology industry include:

Supply-side
- Agilent Technologies
- Becton, Dickinson and Company
- Cardinal Health
- Danaher Corporation
- F. Hoffmann-La Roche
- Merck
- Thermo Fisher Scientific
Demand-side (Laboratories)
- Ampath Laboratories
- Al Borg Medical Laboratories
- Biolab
- Eurofins Scientific
- Laboratoires Réunis
- Lifebrain Group
- Lancet Laboratories
- Medsol Diagnostics
- Synlab Group
- Unilabs

Authors: Mariam Faizullabhoyg, Gauri Wani

Frequently Asked Questions (FAQ) :

The global anatomic pathology industry was valued at approximately USD 36.7 billion in 2023 and is estimated to grow at a 7.8% CAGR from 2024 to 2032, driven by advancements in diagnostic techniques.

The consumables segment led the market with a revenue of USD 19.2 billion in 2023 and is expected to grow significantly due to the essential role of high-quality consumables in improving diagnostic accuracy.

U.S. anatomic pathology market recorded USD 13.6 billion in 2023, driven by the high prevalence of cancer and the need for effective diagnostic solutions.

Key players in the industry include Agilent Technologies, Becton, Dickinson and Company, Cardinal Health, Danaher Corporation, F. Hoffmann-La Roche, Merck, Thermo Fisher Scientific, Ampath Laboratories, Al Borg Medical Laboratories, and Biolab.